| Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently M Leid, P Kastner, R Lyons, H Nakshatri, M Saunders, T Zacharewski, ... Cell 68 (2), 377-395, 1992 | 1432 | 1992 |
| Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor α: a new model for anti-estrogen resistance RA Campbell, P Bhat-Nakshatri, NM Patel, D Constantinidou, S Ali, ... Journal of Biological Chemistry 276 (13), 9817-9824, 2001 | 1278 | 2001 |
| CD44+/CD24-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis C Sheridan, H Kishimoto, RK Fuchs, S Mehrotra, P Bhat-Nakshatri, ... Breast Cancer Research 8, 1-13, 2006 | 1267 | 2006 |
| Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth H Nakshatri, P Bhat-Nakshatri, DA Martin, RJ Goulet Jr, GW Sledge Jr Molecular and cellular biology 17 (7), 3629-3639, 1997 | 1101 | 1997 |
| NF-κ B promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4 G Helbig, KW Christopherson, P Bhat-Nakshatri, S Kumar, H Kishimoto, ... Journal of biological chemistry 278 (24), 21631-21638, 2003 | 837 | 2003 |
| NF-κB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2 HL Chua, P Bhat-Nakshatri, SE Clare, A Morimiya, S Badve, H Nakshatri Oncogene 26 (5), 711-724, 2007 | 736 | 2007 |
| Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production T Starnes, MJ Robertson, G Sledge, S Kelich, H Nakshatri, HE Broxmeyer, ... The Journal of Immunology 167 (8), 4137-4140, 2001 | 490 | 2001 |
| RARs and RXRs: evidence for two autonomous transactivation functions (AF‐1 and AF‐2) and heterodimerization in vivo. S Nagpal, S Friant, H Nakshatri, P Chambon The EMBO journal 12 (6), 2349-2360, 1993 | 420 | 1993 |
| Promoter context-and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors S Nagpal, M Saunders, P Kastner, B Durand, H Nakshatri, P Chambon Cell 70 (6), 1007-1019, 1992 | 417 | 1992 |
| Estradiol-regulated microRNAs control estradiol response in breast cancer cells P Bhat-Nakshatri, G Wang, NR Collins, MJ Thomson, TR Geistlinger, ... Nucleic acids research 37 (14), 4850-4861, 2009 | 389 | 2009 |
| Paclitaxel sensitivity of breast cancer cells with constitutively active NF-κB is enhanced by IκBα super-repressor and parthenolide NM Patel, S Nozaki, NH Shortle, P Bhat-Nakshatri, TR Newton, S Rice, ... Oncogene 19 (36), 4159-4169, 2000 | 376 | 2000 |
| PROGgeneV2: enhancements on the existing database CP Goswami, H Nakshatri BMC cancer 14, 1-6, 2014 | 361 | 2014 |
| FOXA1 expression in breast cancer—correlation with luminal subtype A and survival S Badve, D Turbin, MA Thorat, A Morimiya, TO Nielsen, CM Perou, ... Clinical cancer research 13 (15), 4415-4421, 2007 | 318 | 2007 |
| A retinoic acid response element is present in the mouse cellular retinol binding protein I (mCRBPI) promoter. WC Smith, H Nakshatri, P Leroy, J Rees, P Chambon The EMBO journal 10 (8), 2223-2230, 1991 | 287 | 1991 |
| Mouse retinoic acid receptor alpha 2 isoform is transcribed from a promoter that contains a retinoic acid response element. P Leroy, H Nakshatri, P Chambon Proceedings of the National Academy of Sciences 88 (22), 10138-10142, 1991 | 284 | 1991 |
| Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells R Hromas, HE Broxmeyer, C Kim, H Nakshatri, K Christopherson II, ... Biochemical and biophysical research communications 255 (3), 703-706, 1999 | 234 | 1999 |
| The sesquiterpene lactone parthenolide in combination with docetaxel reduces metastasis and improves survival in a xenograft model of breast cancer CJ Sweeney, S Mehrotra, MR Sadaria, S Kumar, NH Shortle, Y Roman, ... Molecular cancer therapeutics 4 (6), 1004-1012, 2005 | 228 | 2005 |
| Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment E Resetkova, JS Reis-Filho, RK Jain, R Mehta, MA Thorat, H Nakshatri, ... Breast cancer research and treatment 123, 97-108, 2010 | 223 | 2010 |
| Nuclear factor-κB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate C Sweeney, L Li, R Shanmugam, P Bhat-Nakshatri, V Jayaprakasan, ... Clinical Cancer Research 10 (16), 5501-5507, 2004 | 218 | 2004 |
| SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24-phenotype P Bhat-Nakshatri, H Appaiah, C Ballas, P Pick-Franke, R Goulet, S Badve, ... BMC cancer 10, 1-16, 2010 | 203 | 2010 |
Mangesh ThoratCancer Prevention Unit, Wolfson Institute of Population Health, Queen MaryEmail verificata su qmul.ac.uk
